IRAK4- or MyD88-deficient patients suffer from bacterial or viral infections but not from autoimmune diseases, suggesting that targeting of IRAK4 and MyD88 may prevent autoimmunity in humans [110]. This evidence concerns the gene IRAK4 and autoimmune disease.